Comparative Effects Between ELDOA and Spinal Mobilization With Limb Movement in Lumbar Radiculopathy

NCT ID: NCT07328282

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-01

Study Completion Date

2026-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines the comparative effects of ELDOA and Spinal Mobilization with Leg Movement (SMWLM) on lumbar radiculopathy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants were randomly assigned into two groups:

Group A, which performed structured ELDOA exercises targeting spinal decompression and postural alignment Group B, which received SMWLM interventions focusing on spinal mobilization combined with controlled leg movements.

Pain, functional disability, and lumbar range of motion were measured using Visual Analog Scale, Oswestry Disability Index, and bubble inclinometer

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Radiculopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized control trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ELDOA

Group A will recieve standard treatment of ELDOA Strengthening will be divided into following phases

1. Warm up phase:
2. Strengthening phase:
3. Cool down phase:

Group Type EXPERIMENTAL

ELDOA

Intervention Type PROCEDURE

Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises.

Participants in Group A will receive ELDOA in addition to standard physiotherapy. Each position will be sustained for at least one minute, with gradual progression to the full posture as flexibility and control improve.

Spinal mobilization with limb movement

Group B will receive Standard treatment of spinal mobilzation and limb movement Strengthening will be divided into following phases

1. Warm up phase:
2. Strengthening phase:
3. Cool down phase:

Group Type EXPERIMENTAL

Spinal Mobilization with Limb Movement - SMWLM

Intervention Type PROCEDURE

Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group B will receive spinal mobilization combined with limb movement along with standard physiotherapy. The technique will be repeated three times.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ELDOA

Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises.

Participants in Group A will receive ELDOA in addition to standard physiotherapy. Each position will be sustained for at least one minute, with gradual progression to the full posture as flexibility and control improve.

Intervention Type PROCEDURE

Spinal Mobilization with Limb Movement - SMWLM

Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group B will receive spinal mobilization combined with limb movement along with standard physiotherapy. The technique will be repeated three times.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 30 -50 years
* both male and female
* Unilateral lumbar radiculopathy
* Posteriolateral mild disc herniation on MRI
* SLR test positive (30 to 70) degree
* crosed SLR test positive
* Slump test positive

Exclusion Criteria

* MRI findings indicating i. Spinal instability ii. Significant neuroforaminal stenosis iii. Structural abnormalities requiring surgical intervention (e.g., large disc herniation )
* Clinical findings indicating:

i. Absence of severe neurological and severe motor weakness (Manual Muscle Testing grades 0, 1, or 2) ii. Signs of cauda equina lesion (e.g., saddle anesthesia, bowel/bladder dysfunction)
* Diagnosed spinal conditions i. Lumbar spondylolisthesis ii. Lumbar spine fracture iii. Spinal stenosis iv. Spinal tumor v. Ankylosing spondylitis
* History of previous spinal surgery Pregnancy
Minimum Eligible Age

30 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation University College of Physical Therapy

Islamabad, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Uzma Jabeen

Role: CONTACT

0341-3737439

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Uzma Jabeen, DPT

Role: primary

0341-3737439

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2025/21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.